| AChE | acetylcholinesterase inhibitors |
| AD | Alzheimer’s disease |
| BACE1 | beta-Secretase 1 |
| BBB | blood–brain barrier |
| BDNF | brain-derived neurotrophic factor |
| DOPE | dioleylphosphatidylethanolamine |
| FDA | U.S. Food and Drug Administration |
| Lf | lactoferrin |
| MAOIs | monoamine oxidase inhibitors |
| MEM | memantine hydrochloride |
| MRI | magnetic resonance imaging |
| NMDA | N-methyl-d-aspartate |
| NPs | nanoparticles |
| PEG | polyethylene glycol |
| PLA | polylactide acid |
| PLGA | poly lactic-co-glycolic acid |
| RES | reticuloendothelial system |
| SARIs | serotonin antagonists and reuptake inhibitors |
| SLNs | solid lipid nanoparticles |
| SNRIs | serotonin and norepinephrine reuptake inhibitors |
| SPIONs | superparamagnetic iron oxide nanoparticles |
| SSRIs | selective serotonin reuptake inhibitors |
| TCAs | tricyclic antidepressants |